Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.13%
SPX
+0.11%
IXIC
+0.17%
FTSE
+0.69%
N225
+1.05%
AXJO
-1.06%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Financials
laz
Lazard
NYSE: LAZ
-0.48 (-1.14%)
41.49
USD
At close at Apr 02, 20:35 UTC
Summary
News
Signals
Benchmarks
Financials
Join our newsletter to keep up to date with us!

Lazard hires Koski and Lowe to strengthen New York healthcare advisory team

publisher logo
Cashu
about 1 month ago
Cashu TLDR
  • Lazard adds senior dealmakers in New York to expand healthcare advisory capacity.
  • Appointments strengthen Lazard’s ability to advise leadership, boards, and investors on complex healthcare policy and markets.
  • Hires reflect Lazard’s growth strategy recruiting experienced bankers to its entrepreneurial, global platform.
laz Logo
LAZ
Lazard
-1.14%

Lazard bolsters New York healthcare advisory ranks

Lazard, the U.S.-based investment bank, is adding senior dealmakers to its New York Healthcare Group as it seeks to expand advisory capacity in a sector facing rapid policy, payment and technological change. The firm announces John Koski and Rob Lowe as managing directors, reinforcing a hiring push aimed at deepening coverage of payors, providers, distributors and health-tech companies.

Building advisory capacity for complex healthcare deals

The appointments strengthen Lazard’s ability to advise leadership teams, boards and investors navigating evolving healthcare policy, volatile macroeconomic and capital markets conditions, and emerging payment and technology models. David Gluckman, Lazard’s Global Head of Healthcare, says the hires enhance the firm’s capacity to deliver strategic and financial advice on high‑impact transactions as clients confront increasing complexity across the industry.

Koski and Lowe bring senior industry relationships and sector-specific transaction experience that Lazard says will help accelerate deal sourcing and execution in healthcare services. Both join from Allen & Co., where they advised across the payer, provider and health-technology landscape, and Lazard highlights their track records in guiding strategic M&A and capital‑raising assignments that connect traditional healthcare players with digital and payment innovators.

The new additions also reflect Lazard’s longer‑term growth strategy of recruiting experienced bankers attracted to the firm’s entrepreneurial culture and global platform. Management frames the hires as part of a broader push to expand coverage and deliver tailored financial solutions that help clients seize consolidation, partnership and technology-driven opportunities.

Prior roles, education and client focus

Koski combines clinical and financial credentials, having served as a Resident in Orthopedic Surgery at the Hospital for Special Surgery and holding an MD from Yale and an MBA from Harvard Business School. Lowe previously worked in Citi’s Global Healthcare Investment Banking Group and holds an MBA from NYU Stern, giving both a blend of clinical, operational and capital markets insight that Lazard says will be useful to boards and executive teams.

Strategic positioning and firm message

Lazard emphasizes that these hires reinforce its focus on thoughtful, high‑quality strategic advice rather than transactional volume alone. The firm frames the moves as intended to expand client coverage and execution capabilities as healthcare companies respond to shifting reimbursement models, regulatory developments and digital transformation.

The content provided here is for informational purposes only and should not be considered financial or investment advice. Investing in stocks carries risks, including potential loss of principal. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We are not responsible for any losses or damages resulting from your use of this information.

More News

Feature in Progress
This section is under development. Check back soon for updates!